VANCE: First in Human Phase I Study of a Novel ChAdOx1-MVA 5T4 Vaccine

Recent Posts

• Operations Manager
• Study Manager
• Supplies Manager
• Vaccitech Announces Pricing of Initial Public Offering
• Vaccitech Appoints Joseph Scheeren, PharmD, to its Board of Directors